310 The effect of pretreatment with G-CSF prior to dendritic cell collection during the phase IIb trial of an autologous DC-based vaccine for advanced, resectable melanoma

MLA

Phillip M. Kemp Bohan, et al. “310 The Effect of Pretreatment with G-CSF Prior to Dendritic Cell Collection during the Phase IIb Trial of an Autologous DC-Based Vaccine for Advanced, Resectable Melanoma.” Journal for ImmunoTherapy of Cancer, vol. 8, Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....21cf1cf4f509611b3a08ffa37eb5e5d9&authtype=sso&custid=ns315887.

APA

Phillip M. Kemp Bohan, Robert C. Chick, John W. Myers, Timothy J. Vreeland, Montaser Shaheen, Diane F. Hale, Anne E O’Shea, Thomas E. Wagner, Adam C. Berger, Patrick McCarthy, John R. Hyngstrom, Jessica L. Cindass, Jeffrey J. Sussman, Lexy Adams, George E. Peoples, Annelies Hickeron, Tommy A. Brown, Mark B. Faries, Guy T. Clifton, & James W. Jakub. (2020). 310 The effect of pretreatment with G-CSF prior to dendritic cell collection during the phase IIb trial of an autologous DC-based vaccine for advanced, resectable melanoma. Journal for ImmunoTherapy of Cancer, 8.

Chicago

Phillip M. Kemp Bohan, Robert C. Chick, John W. Myers, Timothy J. Vreeland, Montaser Shaheen, Diane F. Hale, Anne E O’Shea, et al. 2020. “310 The Effect of Pretreatment with G-CSF Prior to Dendritic Cell Collection during the Phase IIb Trial of an Autologous DC-Based Vaccine for Advanced, Resectable Melanoma.” Journal for ImmunoTherapy of Cancer 8 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....21cf1cf4f509611b3a08ffa37eb5e5d9&authtype=sso&custid=ns315887.